Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai has obtained Japanese approval for an add-on indication for Vasolan (verapamil hydrochloride) tablets 40 mg and Vasolan for intravenous injection 5mg to treat supraventricular tachyarrhythmia in pediatric patients.
Subscribe to our email newsletter
Vasolan is a calcium channel blocking agent which suppresses tachyarrhythmia by blocking the influx of calcium ions into cells and slowing cardiac excitation.
Currently, Eisai seeks to establish other drug therapies suitable for use in the pediatric setting and remains committed to making further contributions to patients.